Friday, 18 October 2019

Pharma News

  • Sanjiu Medical keeps focus on R&D

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 21 Jun, 2012

    Sanjiu Medical and Pharmaceutical is a manufacturing and marketing company for medicines, healthcare products, and medical instruments. The company also operates in pharmaceutical trading a...Read more

  • Lupin launches generic of Abbott's Tricor

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 21 Nov, 2012

    Mumbai: Lupin's subsidiary Lupin Pharmaceuticals, US, launched its Fenofibrate tablets (48 mg and 145 mg strengths) in the US. Lupin had earlier received final approval for the same from t...Read more

  • FDA trains Indian market to boost exports

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 20 May, 2014

    Singapore: As a measure, to improvise on Indian exports, the US Food and Drug Administration (USFDA) has deputed three senior drug inspectors from the country to Ahmedabad, for a training s...Read more

  • François-Xavier Roge is Takeda's new CFO

    Pharma |  Influencers | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2013

    Singapore: Japan-headquartered global firm, Takeda Pharmaceutical, appointed Mr François-Xavier Roger as its chief financial officer (CFO), effective September 2, 2013.In his new role, M...Read more

  • Novartis, Regenerex further immune tolerance R&D

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2013

    Singapore: Novartis entered into an exclusive global licensing and research collaboration agreement with Regenerex, a biopharmaceutical company based in Louisville, Kentucky, US, for use of...Read more

  • Gilead reports 18% rise in 2012 Q4 revenue

    Pharma |  Company results | By BioSpectrum Bureau  | 0 Comment | 08 Feb, 2013

    Singapore: Gilead Sciences published the results of its operations for the fourth quarter (Q4) and full year 2012. Total revenues for the fourth quarter of 2012 increased 18 percent to $2.5...Read more

  • Boehringer Ingelheim appoints board member

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jul, 2012

    Singapore: The shareholders of Boehringer Ingelheim have appointed Dr Joachim Hasenmaier to Boehringer Ingelheim's board of managing directors. The 52-year-old will take over the responsibi...Read more

  • Eisai seeks nod for cancer, epilepsy drug in S Africa

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2013

    Singapore: Japan-based Eisai has filed two products, Halaven (eribulin) for metastatic breast cancer and Fycompa (perampanel) for epilepsy, for approval with Medicines Control Council (MCC)...Read more

  • Eisai to divest Taiwan plant to Bora

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 11 Feb, 2013

    Singapore: Eisai's Taiwan subsidiary Eisai Taiwan has entered into an agreement to divest its Tainan plant to Taiwanese pharmaceutical company Bora. Since commencing operations in 1974, th...Read more

  • Ranbaxy to market Desvenlafaxine in the US

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 06 Mar, 2013

    Bangalore: Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories, has entered into an in-licensing agreement with Alembic Pharmaceuticals to exclusively market Desvenl...Read more

  • The latest in cancer immunotherapy

    Pharma |  Opinion | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2012

    Immunotherapy is a very active area of cancer research wherein the treatment makes the immune system fight against cancer. Scientists around the world are studying new ways to use immunothe...Read more

  • J&J puts all Chinese units under single local chairman

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Aug, 2013

    Singapore: The business heads of Johnson & Johnson's (J&J) three Chinese operations would report to one local chairman from next month. This move has been made by the firm in an eff...Read more

  • Singapore, Dutch regulators sign health MoU

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 29 Jan, 2013

    Singapore: Health Sciences Authority's (HSA) Asia Regulatory Conference 2013 saw Singapore and Dutch regulators sign a memorandum of understanding (MoU) to collaboratively develop regulatio...Read more

  • Abortion pill among new drugs to be listed on PBS

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2013

    Singapore: Australia's federal health minister Ms Tanya Plibersek has revealed that drugs to treat skin cancer, as well as the controversial abortion pill RU486, will be listed on the pharm...Read more

  • Merck to acquire Idenix for $3.85 billion

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2014

    Singapore: Global pharmaceutical company, Merck, is in process to acquire Idenix Pharmaceuticals, a biopharmaceutical company engaged in the discovery and development of medicines for the t...Read more

  • China develops revolutionary TCM migraine medication

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2012

    Singapore: China Health Resource (CHRI) has developed a revolutionary TCM migraine medication called Toufeng Migraine tablet, which demonstrated an effective rate of 96.5 percent in clinica...Read more

  • Is India suffering from drug pipeline deficit?

    Pharma |  Analysis | By Rahul Koul Koul | 0 Comment | 15 Jan, 2013

    It is estimated that about 40-to-60 percent of the Indian population still doesn't have access to vital life saving drugs. The looming threat of increased mortality rate due to various dise...Read more

  • Bayer seeks nod for Trap-Eye in Japan

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 10 Jan, 2013

    Singapore: Bayer HealthCare announced that Bayer Yakuhin, Osaka, Japan, has submitted an application for marketing authorization for VEGF Trap-Eye (aflibercept solution for injection) for ...Read more



Podcast

 

Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls